GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease

Mesenchymal stem cell (MSC)-based regenerative therapy is regarded as a promising strategy for the treatment of Parkinson’s disease (PD). However, MSC components may exhibit poor intracranial survivability, particularly in the later stages following cell transplantation, limiting their potential cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shoujia, Zhang, Quan, Li, Man, Gao, Pan, Huang, Kuan, Beejadhursing, Rajluxmee, Jiang, Wei, Lei, Ting, Zhu, Mingxin, Shu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444207/
https://www.ncbi.nlm.nih.gov/pubmed/32292068
http://dx.doi.org/10.1177/0963689720908512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444207/
https://www.ncbi.nlm.nih.gov/pubmed/32292068
http://dx.doi.org/10.1177/0963689720908512

Ejemplares similares